- Home
- E vs BDX Comparison
E vs BDX Comparison
Compare E & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- E
- BDX
- Stock Information
- Founded
- E 1953
- BDX 1897
- Country
- E Italy
- BDX United States
- Employees
- E N/A
- BDX N/A
- Industry
- E Oil & Gas Production
- BDX Medical/Dental Instruments
- Sector
- E Energy
- BDX Health Care
- Exchange
- E Nasdaq
- BDX Nasdaq
- Market Cap
- E 52.3B
- BDX 49.0B
- IPO Year
- E 1995
- BDX 1962
- Fundamental
- Price
- E $35.42
- BDX $192.33
- Analyst Decision
- E Buy
- BDX Buy
- Analyst Count
- E 3
- BDX 9
- Target Price
- E $31.60
- BDX $212.88
- AVG Volume (30 Days)
- E 221.4K
- BDX 1.4M
- Earning Date
- E 10-24-2025
- BDX 11-06-2025
- Dividend Yield
- E 4.34%
- BDX 2.16%
- EPS Growth
- E N/A
- BDX 12.91
- EPS
- E 0.86
- BDX 5.47
- Revenue
- E $102,203,170,878.00
- BDX $21,386,000,000.00
- Revenue This Year
- E N/A
- BDX $9.41
- Revenue Next Year
- E N/A
- BDX $4.70
- P/E Ratio
- E $20.12
- BDX $35.20
- Revenue Growth
- E N/A
- BDX 7.86
- 52 Week Low
- E $24.65
- BDX $163.33
- 52 Week High
- E $35.98
- BDX $251.99
- Technical
- Relative Strength Index (RSI)
- E 54.46
- BDX 57.50
- Support Level
- E $34.34
- BDX $190.70
- Resistance Level
- E $35.28
- BDX $195.33
- Average True Range (ATR)
- E 0.34
- BDX 3.32
- MACD
- E -0.01
- BDX 0.83
- Stochastic Oscillator
- E 65.60
- BDX 83.88
About E ENI S.p.A.
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2024, the company produced 0.8 million barrels of liquids and 4.8 billion cubic feet of natural gas per day. At end-2024, Eni held reserves of 6.5 billion barrels of oil equivalent, 46% of which are liquids. The Italian government owns a 30.5% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity called Plenitude, which it will likely list publicly at some point.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.